Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Visit XJP Website

Menu
Change language

简体中文

 

Page navigation

  • ABOUT US
  • OUR PRODUCTS
  • Therapeutic Area
  • Contact Us

Breadcrumb

  1. Home
  2. Therapeutic Area
Multiple Myeloma
Multiple Myeloma

Multiple Myeloma (MM) is a series of hematological malignant disease, in which there is abnormal proliferation of neoplastic plasma cells that secrete large amounts of monoclonal immunoglobulin (M protein), resulting in extensive bone destruction, and repeated infection, anemia, hypercalcemia, hyper viscous syndrome and renal insufficiency. There is high incidence in the middle-aged and elderly people. The overall incidence of MM is 1.5-2/100000, ranking second in hematological malignancies.

PAH
Pulmonary Arterial Hypertension (PAH)

Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure ≥ 25 mmHg at rest measured during right heart catheterization1. Pulmonary Arterial Hypertension (PAH) is the first one of five categories of PH1, which is hemodynamically characterized by pre-capillary pulmonary hypertension (pre-capillary PH). It is defined by pulmonary arterial wedge pressure (PAWP) ≤ 15 mmHg and pulmonary vascular resistance (PVR) >3 Wood units, resulting from causes other than other diseases (including chronic respiratory diseases, chronic thromboembolic diseases and other rare diseases) that may result in pre-capillary PH2.

Therapeutic Area

  • Privacy Policy
  • Privacy Policy for Pharmacovigilance
  • Legal Notice
  • Publicity of Medical Representatives
  • SiteMap
  • Contact Us

FIND US ×

QRcode loading failure... QRcode loading failure...

FIND US:

   

© Johnson & Johnson Pharmaceutical Ltd.2024. All Rights Reserved
This site is published by Johnson & Johnson Pharmaceutical Ltd.
which is solely responsible for all content.
This site is for residents of China only
京ICP备2024054208号 
(京)网药械信息备字(2024)第00072 号
京公网安备11011302007170